Keyphrases
Active Protein
9%
Apoptosis
9%
Cancer Patients
9%
Cell Death
100%
Cell Death Pathways
9%
Cholangiocarcinoma
100%
Cholangiocarcinoma Cell Line
9%
Cholangiocarcinoma Cells
27%
Cholangiocytes
18%
Clinical Samples
9%
Direct Physical Interaction
9%
Dual Life
9%
EIF2
36%
Elevated Protein
9%
Host Defense
9%
Malignant Cells
9%
Nc886
100%
Non-coding RNA (ncRNA)
100%
Nonmalignant
9%
Novel Types
9%
Nuclear factor-κB
9%
Phosphorylation
9%
PKR Activation
9%
Pre-miR
9%
Pro-apoptotic
9%
Pro-survival
9%
Protein Kinase R
100%
Surveillance Model
9%
Tumor Surveillance
9%
Tumorigenesis
27%
Viral Infection
9%
VTRNA2-1
9%
Medicine and Dentistry
Carcinogenesis
27%
Cell Death
100%
Cholangiocarcinoma
100%
Cholangiocarcinoma Cell Line
9%
Cholangiocyte
18%
Host Resistance
9%
Initiation Factor 2
36%
Initiation Factor 2alpha
36%
Malignant Neoplasm
9%
Neoplasm
9%
Nuclear Factor
9%
Programmed Cell Death
9%
Protein Kinase R
100%
Untranslated RNA
100%
Virus Infection
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Carcinoma
100%
Carcinogenesis
27%
Initiation Factor 2
36%
Initiation Factor 2alpha
36%
Malignant Neoplasm
9%
Neoplasm
9%
Nuclear Factor
9%
Protein Kinase R
100%
Untranslated RNA
100%
Virus Infection
9%
Immunology and Microbiology
Cell Death
100%
Cholangiocarcinoma Cell Line
25%
Cholangiocyte
50%
Host Resistance
25%
Initiation Factor 2
100%
Initiation Factor 2alpha
100%
Viral Disease
25%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
27%
Cell Death
100%
Cholangiocyte
18%
Eukaryotic Initiation Factor
36%
Host Resistance
9%
Non-Coding RNA
100%
Protein Kinase R
100%